This video explores the growing role of China as a global hub for innovative biopharma clinical trials, particularly in early-stage development. It discusses why multinational pharmaceutical companies are increasingly conducting Phase 1 and Phase 2 trials in China, highlighting advantages such as faster patient enrollment, strong academic research centers, earlier access to Asian patient data, and accelerated pathways toward simultaneous global commercialization and regulatory approval.
L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2026 L.E.K. Consulting LLC
